Active	Status	Sponsor type	Region	Phase	Filter
6 Active 0 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kataoka, Yu
OPTIMAL, NCT04559191: Atheroma Progression and Vulnerability Under Continuous Glucose Monitoring	Recruiting	4	90	Japan	continuous glucose monitoring (CGM)	National Cerebral and Cardiovascular Center	Coronary Atherosclerosis	12/21	03/22
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)	Recruiting	3	12500	Europe, Canada, Japan, US, RoW	Lepodisiran Sodium, LY3819469, Placebo	Eli Lilly and Company	Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a)	03/29	03/29
GOAL-ASIA, NCT05325034: Guideline Oriented Approach to Lipid Lowering in Asia-Pacific	Recruiting	N/A	2000	Japan, RoW	Early Intervention	Stephen Nicholls, Amgen	Cardiovascular Diseases, Acute Coronary Syndrome, Atherosclerosis, Hypercholesterolemia	12/24	12/24
REASSURE-NIRS, NCT04864171: Registry	Recruiting	N/A	2000	Japan	near-infrared spectroscopy	National Cerebral and Cardiovascular Center	Lipid-Rich Atherosclerosis of Coronary Artery	12/24	03/25
Kasim, Sazzli
TRES, NCT06007950: Time-restricted Eating Study (): Impacts on Anthropometric, Cardiometabolic and Cardiovascular Health	Recruiting	N/A	48	RoW	Time-restricted eating 10-hr	Universiti Teknologi Mara, Ministry of Higher Education, Malaysia	Myocardial Infarction	09/24	09/25
GOAL-ASIA, NCT05325034: Guideline Oriented Approach to Lipid Lowering in Asia-Pacific	Recruiting	N/A	2000	Japan, RoW	Early Intervention	Stephen Nicholls, Amgen	Cardiovascular Diseases, Acute Coronary Syndrome, Atherosclerosis, Hypercholesterolemia	12/24	12/24